$202.08
1.200.60%
At close: -
$201.11
-0.97-0.48%
After Hours: 7:48 PM EDT
Comments
Loading...
Latest news for AbbVie (NYSE:ABBV) Stock
AbbVie Stock (NYSE: ABBV)
Categories: All
Tuesday, February 18, 2025
Monday, February 17, 2025
Friday, February 14, 2025
Wednesday, February 12, 2025
Friday, February 07, 2025
Wednesday, February 05, 2025
Monday, February 03, 2025
- Citigroup Maintains Buy on AbbVie, Raises Pri...
- Looking At AbbVie's Recent Unusual Options Activity
- Nike To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
- Truist Securities Maintains Buy on AbbVie, Ra...
- UBS Maintains Neutral on AbbVie, Raises Price...
- Wells Fargo Maintains Overweight on AbbVie, R...
- AbbVie shares are trading higher after multip...
- Morgan Stanley Maintains Overweight on AbbVie...
- Raymond James Reiterates Outperform on AbbVie...
- Guggenheim Maintains Buy on AbbVie, Raises Pr...
- BMO Capital Maintains Outperform on AbbVie, R...
Friday, January 31, 2025
- Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts
- Tech Stocks Rally, S&P 500 Flirts With Records, Gold Extends All-Time Highs: What's Driving Markets Friday?
- Charter Communications Posts Upbeat Earnings, Joins Atlassian, SkyWest, Eastman Chemical, AbbVie And Other Big Stocks Moving Higher On Friday
- AbbVie Exec Sees An Unfavorable Impact Of 4% ...
- AbbVie Jumps After Q4 Earnings Beat, Skyrizi And Rinvoq Boom Offsets Humira Decline
- AbbVie Expects Net Revenues Of About $12.8B F...
- AbbVie Exec Says Co Expects Humira Revenue Of...
- AbbVie Exec Says Co Anticipates Humira Access...
- AbbVie Exec Says Skyrizi And Rinvoq Are Expec...
- CORRECTION: AbbVie Sees FY25 Adj. EPS $12.12-...
- AbbVie shares are trading higher following be...
- AbbVie Q4 2024 Adj. EPS $2.16 Beats $2.11 Est...
- US Stock Futures Climb After Apple Beats Q1 Expectations: Expert Says Tech Stocks Hold Above Key Level Despite DeepSeek Impact
- Earnings Scheduled For January 31, 2025